Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nucleoside Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel dimethyl phosphonate route for Tenofovir synthesis in patent CN102219805A, offering simplified hydrolysis and significant cost reduction potential.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Novel nucleoside molecule with 3'-hydroxyl blocking group offers enhanced stability and green synthesis for DNA sequencing applications and supply chain efficiency.
Patent CN112321589A details a high-yield Remdesivir synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for antiviral intermediates.
Novel patent CN115181147B enables high-purity nucleoside intermediates with streamlined synthesis for cost-effective pharmaceutical manufacturing supply chains.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.
Patent CN101415719A details efficient L-deoxycytidine production. Offers cost reduction in antiviral manufacturing and reliable supply chain solutions.
Novel synthetic route for Remdesivir intermediates via pyridine coupling, offering improved yield and scalability for pharmaceutical manufacturing supply chains.
Advanced synthetic routes for Entecavir manufacturing offering improved yield and purity. Reliable pharmaceutical intermediate supplier solutions for global supply chains.
Advanced synthesis of Entecavir intermediates via novel epoxide ring-opening. Offers superior purity and cost reduction in antiviral API manufacturing for global supply chains.
Novel synthetic route for Entecavir intermediates avoiding guanine ring-opening. High purity, scalable process for antiviral API manufacturing.
Patent CN108424432B discloses a scalable route for 3'-O-methoxyethyl nucleosides, offering high purity without chromatography for reliable antisense drug supply chains.
Novel scalable route for antisense oligonucleotide intermediates ensuring high purity and cost reduction without preparative chromatography.
Patent CN113004358A details a novel SAM strategy for SeTTP and STTP synthesis, enhancing nucleic acid detection sensitivity and reducing false negatives in PCR.
Patent CN110981863A details a novel route for Sofosbuvir intermediates using unique imidate donors, offering superior beta-selectivity and streamlined purification for API manufacturing.
Patent CN100383128C discloses an efficient route for capecitabine intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN103848876B details a novel nucleoside phosphoramidite prodrug synthesis offering superior HCV inhibition and streamlined manufacturing for pharmaceutical supply chains.
Patent CN102432642B enables high-yield synthesis of antitumor intermediates with reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN101200463B details a cost-effective D-glucose route for 4-thio-D-ribose intermediates, offering significant supply chain advantages over traditional L-lyxose methods.
Novel route from D-glucose reduces cost for 4-thio-nucleoside intermediates. High purity scalable process for antiviral drug synthesis.